Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

Medicine Matters rheumatology

  • Understand that a targeted treatment approach using clearly defined outcomes has the potential to improve outcomes in juvenile idiopathic arthritis (JIA)
  • Understand how imaging and ultrasonography in particular can enhance clinical assessment and support a treat-to-target approach
  • Appreciate that recent international collaborative studies have established an evidence base that will allow the reliable use of ultrasonography in the assessment of children with JIA and other rheumatic disease